SINOMED(SH:688108) Sou Hu Cai Jing·2025-05-21 13:00Core Viewpoint - The news highlights recent stock trading activities by the director of Sino Medical, Cai Wenbin, including a reduction in shareholding and the company's financial performance in the medical device sector [1][2]. Group 1: Stock Trading Activities - On May 20, 2025, Cai Wenbin sold 20,000 shares at an average price of 9.91 yuan, resulting in a transaction amount of 198,200 yuan, leaving him with 136,000 shares [1]. - Cai Wenbin's previous transactions include selling 4,000 shares on May 13, 2025, at 10 yuan, and multiple other trades in early May 2025, indicating a pattern of selling shares in the secondary market [2]. Group 2: Company Overview and Financial Performance - Sino Medical's main business includes the production and operation of Class II and Class III medical devices, along with various technical services and equipment leasing [2]. - As of December 31, 2024, the company's revenue from stents was 261 million yuan, accounting for 56.87% of total revenue, while balloon revenue was 181 million yuan, making up 39.51% [2]. - The total market capitalization of Sino Medical is reported to be 4.11 billion yuan [2].